EUVIMEDEUVIMED entdecken
Crossref

A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services

Samuel R Bunting iD, Aparna Das, Luca Iacobelli, Emily Griner iD, Beth Broussard, Robert O Cotes iD

Psychiatric Services · 2025

DOI: 10.1176/appi.ps.20250098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatric Services, 2025. Verfasst von Samuel R Bunting und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents, Mental Health Services, Health Services Accessibility. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Clozapine is highly effective but underutilized because of patient-, prescriber-, and system-related factors. The purpose of this study was to describe clozapine availability at U.S. mental health facilities. METHODS: A cross-sectional analysis of the 2023 National Substance Use and Mental Health Services Survey was conducted. Clozapine availability was assessed along with facility characteristics associated with odds of clozapine prescription via logistic regression. RESULTS: Among facilities that prescribed antipsychotics (N=6,445), clozapine was available at 58% overall and at 64% that had a dedicated serious mental illness program. Psychiatric hospitals had the highest availability (80%). Outpatient facilities (adjusted odds ratio [AOR]=0.41, p=0.004) were less likely to offer clozapine, and those with serious mental illness programs (AOR=1.57, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAntipsychotic AgentsMental Health ServicesHealth Services AccessibilityHospitals, PsychiatricHumansUnited StatesCross-Sectional Studies

Stichwörter der Autor:innen

AntipsychoticsClozapineCommunity Mental Health CentersCommunity Mental Health ServicesMental Health Systems/HospitalsSchizophrenia

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago.
  • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta.

ORCID-Profile: Samuel R Bunting, Emily Griner, Robert O Cotes

Zitieren

APA

Bunting, S. R., Das, A., Iacobelli, L., Griner, E., Broussard, B., & Cotes, R. O. (2025). A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services. Psychiatric Services. https://doi.org/10.1176/appi.ps.20250098

Vancouver

Bunting SR, Das A, Iacobelli L, Griner E, Broussard B, Cotes RO. A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services. Psychiatric Services. 2025. doi:10.1176/appi.ps.20250098

BibTeX
@article{Bunting2025,
  author = {Bunting, Samuel R and Das, Aparna and Iacobelli, Luca and Griner, Emily and Broussard, Beth and Cotes, Robert O},
  title = {A National Analysis of Facility-Level Clozapine Availability in U.S. Mental Health Services},
  journal = {Psychiatric Services},
  year = {2025},
  doi = {10.1176/appi.ps.20250098}
}
Kostenlos starten →